Skip to main content
Mednow Inc. logo

Mednow Inc. — Investor Relations & Filings

Ticker · MNOW ISIN · CA58503L2021 TSXV Wholesale and retail trade
Open in API
Filings indexed 182 across all filing types
Latest filing 2023-02-10 Regulatory Filings
Country CA Canada
Listing TSXV MNOW

About Mednow Inc.

https://mednow.ca/

Mednow Inc. is a full-service virtual pharmacy utilizing a digital-first approach to deliver prescription medications, over-the-counter products, and comprehensive health services. The company provides fast, free delivery of medications and health products. Core offerings include unlimited virtual consultations with certified pharmacists, prescription management tools accessible via web or mobile application, and direct billing to insurance providers. A key service is PillSmart®, which organizes multiple daily medications into convenient, single-dose packages at no additional cost. Mednow focuses on improving patient access and adherence by offering expert advice and medication reviews seven days a week.

Recent filings

Filing Released Lang Actions
Statement of executive compensation (form 51-102F6V) - English.pdf
Regulatory Filings
2023-02-10 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing the closing of the first tranche of a senior secured convertible debenture financing by Mednow Inc. It details the amount raised, the insider participation, the intended use of proceeds, and regulatory exemptions relied upon. There is no financial statement or detailed financial analysis presented, nor is it a transcript, management report, or governance document. The content focuses on a financing event and capital raising activity. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing, not just an announcement of a report publication or a regulatory filing. Hence, the classification is CAP with high confidence.
2023-02-08 English
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a detailed announcement of Mednow's Q1 2023 financial results, including revenue, EBITDA, segment performance, and operational highlights. It references the period ending October 31, 2022, and includes substantive financial data such as revenue figures, net loss, EBITDA, and adjusted EBITDA. The document also discusses business developments, partnerships, and operational strategies. It explicitly states that the Financial Statements and Management Discussion & Analysis (MD&A) are available on SEDAR and the company's website, indicating this document is a summary or earnings release rather than the full annual or interim report. The length (15,000 characters) and detailed financial data support classification as an Earnings Release (ER), which typically provides key financial highlights and operational updates for a quarter. It is not a full Interim Report (IR) because it does not contain full financial statements or comprehensive analysis, but rather summarized results and commentary. Therefore, the appropriate classification is Earnings Release (ER). Q1 2023
2023-01-18 English
Interim MD&A - English.pdf
Management Reports Classification · 100% confidence The document is titled 'Management's Discussion and Analysis' (MD&A) and provides a detailed review of the company's financial condition, results of operations, cash flows, and strategic initiatives for the three months ended October 31, 2022. It includes financial metrics such as revenue, net loss, EBITDA, and adjusted EBITDA, as well as discussion of business operations, strategic imperatives, and corporate developments. The document references the company's audited consolidated financial statements and is approved by the board of directors. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content matches the definition of a Management Reports (MDA) filing, which includes management's detailed explanation of financial results, business trends, and outlook. Therefore, the appropriate classification is MDA.
2023-01-18 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Mednow Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended October 31, 2022. The document is a certification letter, not the interim report itself, and it explicitly states it is a certificate under National Instrument 52-109. The document length is short (3009 characters) and it contains no actual financial data or substantive financial analysis, only the officer's attestation. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR).
2023-01-18 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CEO of Mednow Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended October 31, 2022. The document is a certification letter and does not contain actual financial statements or substantive financial data. It primarily serves as an officer attestation related to interim filings. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3026 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2023-01-18 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.